LGALS1 and cancer: This promising inhibitor in treating patients with elevated Gal-1 levels has so far shown to significantly reduce Gal-1 serum levels in a clinical trial study [12] and from our study, we have also demonstrated the efficiency in Gal-1 activity and inhibiting various cancer cell related processes.